UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 430

Sortiert nach

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study

Alimentary pharmacology & therapeutics, 2013-03, Vol.37 (6), p.604-612

2013

Volltextzugriff (PDF)

High‐dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Alimentary pharmacology & therapeutics, 2011-11, Vol.34 (10), p.1185-1192

2011

Volltextzugriff (PDF)

Recurrent Primary Biliary Cirrhosis After Liver Transplantation

American journal of transplantation, 2010-04, Vol.10 (4), p.720-726

2010

Volltextzugriff (PDF)

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

Hepatology (Baltimore, Md.), 1999-12, Vol.30 (6), p.1356-1362

1999

Volltextzugriff (PDF)

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

Gastroenterology (New York, N.Y. 1943), 1997-09, Vol.113 (3), p.884-890

1997

Volltextzugriff (PDF)

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

The American journal of gastroenterology, 1999-04, Vol.94 (4), p.1018-1022

1999

Volltextzugriff (PDF)

Primary sclerosing cholangitis

Hepatology (Baltimore, Md.), 1999-07, Vol.30 (1), p.325-332

1999

Volltextzugriff (PDF)

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (2), p.255-265

2012

Volltextzugriff (PDF)

Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol

Alimentary pharmacology & therapeutics, 2008-10, Vol.28 (7), p.886-894

2008

Volltextzugriff (PDF)

Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: A pilot study

Hepatology (Baltimore, Md.), 1996-06, Vol.23 (6), p.1464-1467

1996

Volltextzugriff (PDF)

Ursodiol for Primary Sclerosing Cholangitis

The New England journal of medicine, 1997-03, Vol.336 (10), p.691-695

Lindor, Keith D

1997

Volltextzugriff (PDF)

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.886-895

2018

Volltextzugriff (PDF)

A revised natural history model for primary sclerosing cholangitis

Mayo Clinic proceedings, 2000-07, Vol.75 (7), p.688-694

2000

Volltextzugriff (PDF)

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1226-1227

2018

Volltextzugriff (PDF)

Metabolic and Nutritional Considerations in Nonalcoholic Fatty Liver

Hepatology, 2000-07, Vol.32 (1), p.3-10

2000

Volltextzugriff (PDF)

Review article: nuclear receptors and liver disease – current understanding and new therapeutic implications

Alimentary pharmacology & therapeutics, 2009-10, Vol.30 (8), p.816-825

2009

Volltextzugriff (PDF)

A randomized prospective study comparing rigid to balloon dilators for benign esophageal strictures and rings

Gastrointestinal endoscopy, 1999-07, Vol.50 (1), p.13-17

1999

Volltextzugriff (PDF)

Treatment of Nonalcoholic Fatty Liver: Present and Emerging Therapies

Seminars in liver disease, 2001, Vol.21 (1), p.081-088

2001

Volltextzugriff (PDF)

Unsedated small-caliber esophagogastroduodenoscopy (EGD) versus conventional EGD: A comparative study

Gastroenterology (New York, N.Y. 1943), 1999-12, Vol.117 (6), p.1301-1307

1999

Volltextzugriff (PDF)

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

Hepatology (Baltimore, Md.), 2000-02, Vol.31 (2), p.318-323

2000

Volltextzugriff (PDF)

Insulin resistance and mitochondrial abnormalities in NASH: A cool look into a burning issue

Gastroenterology (New York, N.Y. 1943), 2001-04, Vol.120 (5), p.1281-1285

2001

Volltextzugriff (PDF)

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

Gastroenterology (New York, N.Y. 1943), 1996-05, Vol.110 (5), p.1515-1518

1996

Volltextzugriff (PDF)

Long‐term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

Hepatology (Baltimore, Md.), 1999-03, Vol.29 (3), p.644-647

1999

Volltextzugriff (PDF)

Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo‐controlled treatment trial

Hepatology (Baltimore, Md.), 1999-12, Vol.30 (6), p.1381-1386

1999

Volltextzugriff (PDF)

Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease

Alimentary pharmacology & therapeutics, 2015-03, Vol.41 (5), p.490-490

2015

Volltextzugriff (PDF)

1 – 25 von 430

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(412)
Mit Volltextzugriff
(348)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(300)
Science & Technology
(297)
Life Sciences & Biomedicine
(292)
Female
(196)
Gastroenterology & Hepatology
(193)
Male
(187)
Middle Aged
(180)
Biological And Medical Sciences
(172)
Medical Sciences
(171)
Adult
(156)
Aged
(114)
Gastroenterology. Liver. Pancreas. Abdomen
(101)
Other Diseases. Semiology
(78)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(75)
Ursodeoxycholic Acid - Therapeutic Use
(67)
Risk Factors
(58)
Liver Cirrhosis, Biliary - Drug Therapy
(55)
Digestive System
(48)
Pharmacology. Drug Treatments
(45)
Cholagogues And Choleretics - Therapeutic Use
(42)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study

High‐dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Recurrent Primary Biliary Cirrhosis After Liver Transplantation

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

Primary sclerosing cholangitis

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study

Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol

Ursodeoxycholic acid or clofibrate in the treatment of non‐alcohol‐induced steatohepatitis: A pilot study

Ursodiol for Primary Sclerosing Cholangitis

Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis

A revised natural history model for primary sclerosing cholangitis

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Metabolic and Nutritional Considerations in Nonalcoholic Fatty Liver

Review article: nuclear receptors and liver disease – current understanding and new therapeutic implications

A randomized prospective study comparing rigid to balloon dilators for benign esophageal strictures and rings

Treatment of Nonalcoholic Fatty Liver: Present and Emerging Therapies

Unsedated small-caliber esophagogastroduodenoscopy (EGD) versus conventional EGD: A comparative study

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

Insulin resistance and mitochondrial abnormalities in NASH: A cool look into a burning issue

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

Long‐term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo‐controlled treatment trial

Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease

Suchergebnisse filtern